Company Analysis

BridgeBio Pharma, Inc. (BBIO)

Nasdaq: BBIO · Pharmaceutical Preparations · Palo Alto, CA · filing with the SEC since 2018
Grade6.2
◀ Past 6.4● Present 6.4▶ Future 5.7
1 est.

Filings

298 filings since 2017 beside 536 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 29 days after the quarter ended. The proxy statement was last filed Apr 24, 2026.

Filings a yearinsider forms included
8515583629385149111
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Jun 26, 2026.
Insider forms 536

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 29, 2026 10-Q Quarterly report Sep 30, 2026
Oct 29, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 27, 2026 SCHEDULE 13G Large holder notice
Oct 13, 2026 8-K items 8.01, 9.01 Other event · Current report Oct 6, 2026
Aug 31, 2026 8-K items 8.01, 9.01 Other event · Current report
Aug 17, 2026 SCHEDULE 13D/A Activist holder update, amended
Aug 17, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Aug 13, 2026
Aug 14, 2026 424B7 Resale prospectus supplement
Aug 10, 2026 10-Q Quarterly report Jun 30, 2026
Aug 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 3, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 27, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 24, 2026 S-3ASR Shelf registration
Jul 24, 2026 S-8 Employee stock plan registration
Jul 22, 2026 8-K items 8.01, 9.01 Other event · Current report
Jul 10, 2026 SCHEDULE 13D/A Activist holder update, amended
Jun 26, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Jun 22, 2026
May 29, 2026 SCHEDULE 13G Large holder notice
May 27, 2026 8-K items 8.01, 9.01 Other event · Current report
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 13, 2026 8-K items 8.01, 9.01 Other event · Current report May 12, 2026
May 8, 2026 8-K items 1.01, 1.02, 9.01 Major agreement signed; Major agreement ended · Current report May 7, 2026
May 8, 2026 S-3ASR Shelf registration
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 8.01 Results released; Other event · Current report May 6, 2026
Apr 24, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 24, 2026 DEFA14A Extra proxy material
Apr 24, 2026 DEF 14A Proxy statement Jun 22, 2026
Apr 16, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 2, 2026 SCHEDULE 13D/A Activist holder update, amended
Mar 30, 2026 8-K items 8.01, 9.01 Other event · Current report
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 24, 2026 10-K Annual report Dec 31, 2025
Feb 24, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 17, 2026 SCHEDULE 13G Large holder notice
Feb 17, 2026 SCHEDULE 13D/A Activist holder update, amended
Feb 12, 2026 8-K items 8.01, 9.01 Other event · Current report
Jan 21, 2026 8-K items 1.01, 2.03, 3.02, 8.01, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration; Other event · Current report Jan 14, 2026
40 of 298 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton BBIO · research, not advice